RESEARCH IS KEY!!
Study: Newly Identified Genes Linked with Higher Risk for Triple-Negative Breast Cancer..
A team of researchers in Rochester, Minnesota recently discovered mutations in 5 genes that seem to increase the risk for TNBC. These genes are known by several names: breast-cancer-risk genes, cancer-predisposition genes, and cancer-susceptibility genes. The research team was led by Fergus J. Couch, PhD, the Zbigniew and Anna M. Scheller Professor of Medical Research and Chair of the Division of Experimental Pathology and Laboratory Medicine at the Mayo Clinic.
TNBC tends to be more aggressive than other common types of breast cancer.
Women usually don’t learn they have it until the cancer has already spread to other parts of the body (metastasized), so it may be more complicated to treat.
Treatment options remain limited. Hormone therapies and targeted therapies that help treat people with some types of breast cancer, don’t work for a woman with TNBC. Doctors use chemotherapy to treat these patients, but it isn’t very effective and may have a lot of side effects…
READ MORE HERE…